Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$874
|
$815B |
17.3x |
47.2x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$202
|
$418B |
7.4x |
16.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$162
|
$403B |
4.5x |
12.8x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 630
|
$401B |
9.6x |
19.6x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 301
|
$293B |
4.3x |
11.2x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£116
|
$251B |
4.5x |
13.5x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$89
|
$250B |
3.9x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 98
|
$232B |
4.6x |
11.1x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$533
|
$227B |
5.3x |
20.7x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$303
|
$211B |
6.3x |
10.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$206B |
3.2x |
8.5x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$210
|
$165B |
6.9x |
21.8x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$155B |
5.4x |
13.6x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$56
|
$154B |
3.2x |
19.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€104
|
$146B |
3.1x |
10.8x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$484
|
$120B |
10.8x |
75.8x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$90.8B |
2.3x |
6.5x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7685
|
$77.0B |
9.9x |
20.2x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$160
|
$76.6B |
8.3x |
19.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4218
|
$72.7B |
2.4x |
8.9x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$700
|
$70.3B |
4.9x |
12.7x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€136
|
$69.7B |
3.1x |
11.0x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1157000
|
$57.1B |
17.6x |
43.4x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€22
|
$55.8B |
1.2x |
5.3x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.4B |
3.8x |
15.4x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 584
|
$49.8B |
6.7x |
23.1x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$191
|
$46.0B |
3.0x |
12.4x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1644
|
$43.3B |
7.2x |
25.2x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$135
|
$40.7B |
6.2x |
21.0x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 48
|
$39.1B |
10.4x |
42.4x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3429
|
$38.0B |
3.2x |
17.2x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€180
|
$37.9B |
6.1x |
23.4x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$453
|
$37.7B |
9.6x |
28.9x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€616
|
$35.9B |
15.3x |
374.1x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$34.8B |
2.1x |
7.1x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€36
|
$32.2B |
1.4x |
8.7x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$251
|
$31.0B |
13.3x |
1401.2x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1287
|
$28.9B |
7.4x |
22.9x |
BeiGene
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 165
|
$27.9B |
7.2x |
-76.6x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 178200
|
$27.7B |
11.0x |
36.7x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$27.4B |
1.9x |
5.9x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$250
|
$26.6B |
2.0x |
12.0x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 68
|
$26.0B |
4.8x |
13.5x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$172
|
$25.7B |
2.6x |
13.1x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$141
|
$24.8B |
2.6x |
7.5x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7194
|
$23.8B |
1.5x |
7.2x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$375
|
$23.6B |
7.9x |
21.9x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€209
|
$23.4B |
8.0x |
28.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$23.1B |
2.4x |
6.9x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1466
|
$22.0B |
1.8x |
8.9x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$162
|
$21.0B |
12.5x |
-118.7x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$33
|
$20.3B |
7.2x |
7.8x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$283
|
$20.3B |
9.5x |
43.4x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 42
|
$19.9B |
1.9x |
9.5x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$201
|
$19.3B |
2.3x |
11.2x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5757
|
$17.2B |
16.3x |
52.4x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 205
|
$16.7B |
10.7x |
31.6x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$94
|
$16.3B |
3.7x |
13.9x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$114
|
$16.0B |
5.8x |
18.7x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$15.9B |
N/A |
-69.8x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€8
|
$14.7B |
2.0x |
8.0x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 392000
|
$14.4B |
222.2x |
822.0x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€115
|
$14.4B |
3.5x |
15.0x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$14.4B |
37.9x |
-16.5x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$361
|
$13.2B |
4.5x |
8.6x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€55
|
$13.2B |
5.3x |
14.4x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 26
|
$13.0B |
5.1x |
15.5x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1474
|
$12.8B |
4.0x |
15.7x |
Intra-Cellular Therapies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$12.7B |
17.7x |
-143.5x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€49
|
$12.5B |
1.7x |
7.7x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$68
|
$12.5B |
4.3x |
19.0x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3039
|
$12.0B |
9.1x |
28.1x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$12.0B |
1.9x |
6.1x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 20
|
$11.9B |
7.1x |
20.1x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$11.8B |
2.8x |
39.8x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$11.8B |
2.9x |
6.4x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$11.7B |
2.1x |
15.9x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$120
|
$11.6B |
4.2x |
-10.1x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 312
|
$11.5B |
4.6x |
12.8x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$121
|
$11.4B |
4.8x |
17.2x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 69
|
$11.3B |
30.2x |
98.7x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1583
|
$11.2B |
3.6x |
11.0x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 23
|
$11.2B |
1.9x |
13.1x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 209
|
$11.1B |
14.7x |
22.9x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1152
|
$11.0B |
3.0x |
10.9x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$49
|
$10.9B |
3.9x |
32.1x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$163
|
$10.9B |
2.7x |
11.0x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2327
|
$10.6B |
7.6x |
29.1x |
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$65
|
$10.5B |
8.7x |
24.9x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$106
|
$10.3B |
5.1x |
19.5x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1906
|
$10.0B |
3.9x |
17.1x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 885
|
$9.9B |
3.8x |
13.1x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$340
|
$9.8B |
4.6x |
20.5x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 27
|
$9.6B |
2.4x |
17.5x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€148
|
$9.6B |
N/A |
N/A |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 22
|
$9.5B |
3.2x |
8.1x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$9.4B |
4.3x |
13.9x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$11
|
$9.3B |
2.1x |
10.3x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$128
|
$9.2B |
1.2x |
7.6x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2257
|
$8.9B |
3.0x |
7.3x |